Anti-OSBPL5 monoclonal antibody

Pre-made anti-OSBPL5 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to OSBPL5/OSBPL5 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP1309-Ab-1/ GM-Tg-hg-IP1309-Ab-2Anti-Human OSBPL5 monoclonal antibodyHuman
GM-Tg-rg-IP1309-Ab-1/ GM-Tg-rg-IP1309-Ab-2Anti-Rat OSBPL5 monoclonal antibodyRat
GM-Tg-mg-IP1309-Ab-1/ GM-Tg-mg-IP1309-Ab-2Anti-Mouse OSBPL5 monoclonal antibodyMouse
GM-Tg-cynog-IP1309-Ab-1/ GM-Tg-cynog-IP1309-Ab-2Anti-Cynomolgus/ Rhesus macaque OSBPL5 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP1309-Ab-1/ GM-Tg-felg-IP1309-Ab-2Anti-Feline OSBPL5 monoclonal antibodyFeline
GM-Tg-cang-IP1309-Ab-1/ GM-Tg-cang-IP1309-Ab-2Anti-Canine OSBPL5 monoclonal antibodyCanine
GM-Tg-bovg-IP1309-Ab-1/ GM-Tg-bovg-IP1309-Ab-2Anti-Bovine OSBPL5 monoclonal antibodyBovine
GM-Tg-equg-IP1309-Ab-1/ GM-Tg-equg-IP1309-Ab-2Anti-Equine OSBPL5 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP1309-Ab-1/ GM-Tg-hg-IP1309-Ab-2; GM-Tg-rg-IP1309-Ab-1/ GM-Tg-rg-IP1309-Ab-2;
GM-Tg-mg-IP1309-Ab-1/ GM-Tg-mg-IP1309-Ab-2; GM-Tg-cynog-IP1309-Ab-1/ GM-Tg-cynog-IP1309-Ab-2;
GM-Tg-felg-IP1309-Ab-1/ GM-Tg-felg-IP1309-Ab-2; GM-Tg-cang-IP1309-Ab-1/ GM-Tg-cang-IP1309-Ab-2;
GM-Tg-bovg-IP1309-Ab-1/ GM-Tg-bovg-IP1309-Ab-2; GM-Tg-equg-IP1309-Ab-1/ GM-Tg-equg-IP1309-Ab-2
Products NameAnti-OSBPL5 monoclonal antibody
Formatmab
Target NameOSBPL5
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-OSBPL5 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP1309-Ag-1Recombinant multi-species OSBL5/ OSBPL5/ OBPH1 protein
    ORF Viral VectorvGMLP004408human OSBPL5 Lentivirus particle
    ORF Viral VectorpGMLP004408human OSBPL5 Lentivirus plasmid


    Target information

    Target IDGM-IP1309
    Target NameOSBPL5
    Gene ID114879,79196,361686,706613,483671,101089395,532690,100147251
    Gene Symbol and Synonyms1110006M06Rik,OBPH1,ORP5,Osbp2,OSBPL5
    Uniprot AccessionQ9H0X9
    Uniprot Entry NameOSBL5_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000021762
    Target ClassificationN/A

    The target: OSBPL5, gene name: OSBPL5, also named as OBPH1, ORP5. This gene encodes a member of the oxysterol-binding protein (OSBP) family, a group of intracellular lipid receptors that play a key role in the maintenance of cholesterol balance in the body. Most members contain an N-terminal pleckstrin homology domain and a highly conserved C-terminal OSBP-like sterol-binding domain. This gene has been shown to be imprinted, with preferential expression from the maternal allele only in placenta. Transcript variants encoding different isoforms have been identified. [provided by RefSeq, Oct 2010].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.